|
Kandrashkina Yu.A., Orlova E.A., Kostina E.M.
The role of Substance P in the pathogenesis and treatment of some skin diseases
|
№6 / 2024
|
|
Sokolovsky E.V., Kholodilova N.A., Monakhov K.N.
Atopic dermatitis: current treatment options
|
№6 / 2024
|
|
Kukushkina A.D., Davydovskaya M.V., Khachanova N.V., Popova E.V., Ponevezhskaya E.V., Lysogorskaya E.V.
A case of rebound effect when switching from natalizumab to another highly effective drug in a patient with multiple sclerosis
|
№6 / 2024
|
|
Chubykina S.V., Tatarinova M.Yu., Avakyan G.G., Knyazev R.I.
Neurophysiological manifestations of neuropathy induced by taxane and platinum chemotherapeutic agents
|
№6 / 2024
|
|
Kolykhalov I.V.
New approaches to diagnostics and therapy of vascular dementia
|
№6 / 2024
|
|
Vizilo T.L., Poponnikova T.V., Fedoseeva I.F., Vizilo A.D.
Correction of asthenia in outpatient clinical practice
|
№6 / 2024
|
|
Moiseeva M.V., Mordyk A.V., Bagisheva N.V., Shapran A.A., Shcherbakova L.E., Mordyk D.I.
Health schools as a method of infectious disease prevention in patients with chronic somatic pathology
|
№6 / 2024
|
|
Temirbulatov I.I., Abdullaev Sh.P., Denisenko N.P., Kryukov A.V., Tuchkova S.N., Mirzaev K.B., Averkov O.V., Vechorko V.I., Sychev D.A.
Association between CES1, CYP3A genetic polymorphisms and remdesivir hepatotoxicity in patients with COVID-19
|
№6 / 2024
|
|
Samorodov N.A., Sabanchieva Zh.Kh., Shmeleva S.V., Logachev N.V.
Comparative analysis of the results of examination and surgical treatment of patients with pulmonary tuberculosis in the antituberculosis and general medical network
|
№6 / 2024
|
|
Ryagin S.N., Sidnyaev V.A., Gerbig N.A., Kamyshnikova E.A.
Pharmacognostic study of Аconitum soongaricum roots
|
№6 / 2024
|
|
Samorodov N.A., Sabanchieva Zh.Kh., Shmeleva S.V., Dubrovinskaya E.I.
Experience with endoscopic valvular broncoblockation
|
№6 / 2024
|
|
De V.A., Kochetkov A.I., Abdullaev Sh.P., Bochkov P.O., Klepikova M.V., Batyukina S.V., Mirzaev K.B., Ostroumova O.D.
On the possible relationship between polymorphic variants of the CYP2C19 gene, residual concentration and the presence of bleeding in patients who have suffered acute coronary syndrome and are receiving clopidogrel as part of dual antithrombotic therapy
|
№6 / 2024
|
Русский
